Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

Clinical trial NCT01226797 · TERMINATED

Trial details

NCT number: NCT01226797
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-01-17
Primary completion: 2012-02-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.